Alpha-1 and Your Child’s Liver What Parents Need to Knowunderstanding Alpha-1 Antitrypsin Deficiency

If your baby or child has been told they might have Alpha-1, you probably have a lot of questions and not much sleep. That is completely understandable. The most important thing to know first is that most children with Alpha-1 become stable over time, and the liver tests of many children return to normal as they grow. This article explains what Alpha-1 can do to a child’s liver, what doctors look for, and where families can find support in Australia. If you’d like the basics first, start with our guide to understanding Alpha-1 Antitrypsin Deficiency.

In short

  • Alpha-1 is inherited. Children with two abnormal PiZZ genes carry the highest risk of liver disease.
  • Liver problems usually show up in the first few months of life, but many children’s liver tests settle over time.
  • A small number of children develop liver failure and need a liver transplant in the first two years. A transplant cures Alpha-1 liver disease.
  • There is no cure for the liver disease yet, but there is close monitoring, good supportive care, and clinical trials underway.
  • Brothers, sisters and biological parents should be tested.

What is Alpha-1, and why does it affect the liver?

The liver makes a protein called alpha-1 antitrypsin, which normally travels through the blood to protect the lungs and other organs. In Alpha-1, a gene change means the protein can be made in low amounts, destroyed, or become stuck inside the liver. In children, the trapped protein is what can cause liver trouble. For the full picture, including adults, see our article on Alpha-1 liver disease: causes, symptoms, diagnosis and treatment.

The normal gene version is called PiMM. Children with two abnormal PiZZ genes are at higher risk. The S variant doesn’t seem to cause childhood liver disease.

How likely is it that my child will have liver problems?

Our fact sheet states that about 10% of children with Alpha-1 have severe liver problems. Some PiZZ babies are born with liver disease, while others develop it later in childhood. Published estimates differ between studies, so ask your child’s specialist what applies to your child. The reassuring part is that many PiZZ children have abnormal liver tests that return to normal during childhood.

Signs to look out for

  • Jaundice (yellow skin or eyes), sometimes lasting longer than in other babies
  • Poor weight gain
  • Darker urine
  • Pale stools (poo)
  • A swollen tummy from fluid (ascites)
  • High blood pressure in the blood vessels around the liver (portal hypertension)
  • Bleeding

When to get help: A baby with persistent jaundice, pale stools or dark urine should be checked by a doctor promptly. Don’t wait to see if it settles. If you notice bleeding or your child seems unwell, seek urgent medical care.

You may hear the term neonatal hepatitis. In this context it is not contagious.

What happens after diagnosis?

Your child’s team will keep a close eye on how the liver is working, usually through:

  • Blood tests
  • Scans
  • Sometimes a liver biopsy
  • Growth and development checks

This is so any complication can be spotted and treated quickly. At the moment there are no strategies to prevent the liver problems and no specific treatment to stop them, but supportive care makes a real difference.

How is it treated day to day?

  • Feeding: A damaged liver makes less bile, so children may not absorb food well and can struggle to gain weight. The team may adjust milk, diet or kilojoules.
  • Vitamins: Some children need supplements, especially vitamin K, which helps blood clot.
  • Transplant: If liver failure develops, a transplant can be life-saving. Read what to expect in Liver Transplantation and Alpha-1: What Australians Need to Know, which lists the adult and paediatric transplant units across Australia.
  • Research: There is no cure yet, but clinical trials are underway. Our latest news is on the homepage.

Who else in the family should be tested?

Brothers, sisters and biological parents should be tested. Alpha-1 can also affect the lungs later in life, so family testing matters beyond the liver. See our article on Alpha-1 lung disease. If you’re thinking about having more children, a genetic counsellor can talk through your options.

Looking after yourself

[PLACEHOLDER: a short, real quote from an A1OA parent member, with their consent, about the first weeks after diagnosis.]

A sick child is distressing, and many parents find talking to others who’ve been there helps. A1OA runs a video support group, and there are Australian and international Alpha-1 Facebook groups, including one for families of children with Alpha-1. A counsellor can help too.

  • Contact A1OA to be connected with another family
  • Become a member for newsletters and extra resources
  • Browse more liver resources and fact sheets

Download the printable Fact Sheet (PDF)

Frequently Asked Questions

Common questions about Alpha-1, childhood liver disease, diagnosis, treatment and family testing.

Is neonatal hepatitis contagious?

No. It is not the same as infectious hepatitis.

Will my child need a liver transplant?

Most children won’t. A small number develop liver failure, usually PiZZ children, in the first two years of life. Learn more about what liver transplantation involves.

Can liver tests go back to normal?

Yes. Many PiZZ children have abnormal liver results that return to normal during childhood.

Is there a cure?

Not yet for the liver disease, but monitoring, supportive care and clinical trials continue. A transplant cures it if one is needed.

Who should be tested?

Brothers, sisters and biological parents of an affected child. Learn more on our Understanding A1AD page.

Gaynor Heading, President of Alpha-1 Organisation Australia

About the Author, Gaynor Heading

Gaynor Heading holds a PhD in Medicine and is President of Alpha-1 Organisation Australia. She is a former Associate Professor with the University of Sydney with publications in respiratory health and health professional education, and has held competitive research grants including an NH&MRC grant. She brings extensive experience in public health, consumer advocacy and community liaison.